(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Travelzoo, TherapeuticsMD, and NRG Energy.

The three biggest losers today are AGM Group Holdings, Wheeler Real Estate Investment Trust, and VerifyMe.

Winners today

1. Travelzoo (TZOO) – 9.6%

Travelzoo, an Internet media company, provides travel, entertainment, and local deals from travel and entertainment companies, and local businesses in the Asia Pacific, Europe, and North America. Its publications and products include Travelzoo Website; Travelzoo iPhone and Android apps; Travelzoo Top 20 email newsletter; and Newsflash email alert service. The company also operates the Travelzoo Network, a network of third-party Websites that list travel deals published by the company; and Local Deals and Getaway listings, which allow its members to purchase vouchers for deals from local businesses, such as spas, hotels, and restaurants. It serves airlines, hotels, cruise lines, vacations packagers, tour operators, destinations, car rental companies, travel agents, theater and performing arts groups, restaurants, spas, and activity companies. Travelzoo Inc. was founded in 1998 and is headquartered in New York, New York.

NASDAQ ended the session with Travelzoo jumping 9.6% to $9.02 on Friday while NASDAQ dropped 0.35% to $12,284.74.

Earnings Per Share

As for profitability, Travelzoo has a trailing twelve months EPS of $0.61.

PE Ratio

Travelzoo has a trailing twelve months price to earnings ratio of 14.79. Meaning, the purchaser of the share is investing $14.79 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 100.23%.

Moving Average

Travelzoo’s value is way higher than its 50-day moving average of $6.01 and way higher than its 200-day moving average of $5.45.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 100% and 33.3%, respectively.

Previous days news about Travelzoo

• Travelzoo invites a million people into its travel metaverse. According to VentureBeat on Wednesday, 10 May, "After months of preparation, Travelzoo Meta is the company’s effort to create the future of travel. ", "With sign-ups now open, Travelzoo Meta invites those who share a vision of a world that ebbs and flows as far as the mind wanders to become founding members."

More news about Travelzoo.

2. TherapeuticsMD (TXMD) – 8.09%

TherapeuticsMD, Inc. operates as a pharmaceutical company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

NASDAQ ended the session with TherapeuticsMD jumping 8.09% to $4.32 on Friday, after two sequential sessions in a row of gains. NASDAQ fell 0.35% to $12,284.74, after two sequential sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, TherapeuticsMD has a trailing twelve months EPS of $0.11.

PE Ratio

TherapeuticsMD has a trailing twelve months price to earnings ratio of 39.3. Meaning, the purchaser of the share is investing $39.3 for every dollar of annual earnings.

Sales Growth

TherapeuticsMD’s sales growth is negative 91.2% for the present quarter and negative 93.7% for the next.

More news about TherapeuticsMD.

3. NRG Energy (NRG) – 5.09%

NRG Energy, Inc., together with its subsidiaries, operates as an integrated power company in the United States. It operates through Texas, East, and West segments. The company is involved in producing and selling electricity and related products and services to approximately residential, commercial, industrial, and wholesale customers. It generates electricity using natural gas, coal, oil, solar, nuclear, and battery storage. The company also provides system power, distributed generation, renewable products, backup generation, storage and distributed solar, demand response, and energy efficiency and advisory services, as well as carbon management and specialty services. In addition, it trades in electric power, natural gas, and related commodities; environmental products; weather products; and financial products, including forwards, futures, options, and swaps. Further, the company procures fuels; and sells energy, services, and products and services under the NRG, Reliant, Direct Energy, Green Mountain Energy, Stream, and XOOM Energy. NRG Energy, Inc. was founded in 1989 and is headquartered in Houston, Texas.

NYSE ended the session with NRG Energy jumping 5.09% to $32.62 on Friday while NYSE dropped 0.11% to $15,246.36.

Earnings Per Share

As for profitability, NRG Energy has a trailing twelve months EPS of $-7.75.

More news about NRG Energy.

4. AdaptHealth Corp. (AHCO) – 5.05%

AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; home medical equipment (HME) to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

NASDAQ ended the session with AdaptHealth Corp. jumping 5.05% to $10.60 on Friday while NASDAQ fell 0.35% to $12,284.74.

Earnings Per Share

As for profitability, AdaptHealth Corp. has a trailing twelve months EPS of $0.29.

PE Ratio

AdaptHealth Corp. has a trailing twelve months price to earnings ratio of 36.55. Meaning, the purchaser of the share is investing $36.55 for every dollar of annual earnings.

Volume

Today’s last reported volume for AdaptHealth Corp. is 1542360 which is 2.47% above its average volume of 1505170.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 11.1% and 90.9%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

AdaptHealth Corp. ‘s EBITDA is 95.27.

Yearly Top and Bottom Value

AdaptHealth Corp. ‘s stock is valued at $10.60 at 17:32 EST, way under its 52-week high of $27.48 and higher than its 52-week low of $10.00.

More news about AdaptHealth Corp. .

5. Petroleo Brasileiro (PBR) – 4.77%

Petróleo Brasileiro S.A. – Petrobras explores, produces, and sells oil and gas in Brazil and internationally. The company operates through Exploration and Production; Refining, Transportation and Marketing; and Gas and Power. It also engages in prospecting, drilling, refining, processing, trading, and transporting crude oil from producing onshore and offshore oil fields, and shale or other rocks, as well as oil products, natural gas, and other liquid hydrocarbons. The Exploration and Production segment explores, develops, and produces crude oil, natural gas liquids, and natural gas primarily for supplies to the domestic refineries. The Refining, Transportation and Marketing segment engages in the refining, logistics, transport, marketing, and trading of crude oil and oil products; exportation of ethanol; and extraction and processing of shale, as well as holding interests in petrochemical companies. The Gas and Power segment is involved in the logistic and trading of natural gas and electricity; transportation and trading of LNG; generation of electricity through thermoelectric power plants; holding interests in transportation and distribution of natural gas; and fertilizer production and natural gas processing business. In addition, the company produces biodiesel and its co-products, and ethanol; and distributes oil products. Further, it engages in research, development, production, transport, distribution, and trading of energy. Petróleo Brasileiro S.A. – Petrobras was incorporated in 1953 and is headquartered in Rio de Janeiro, Brazil.

NYSE ended the session with Petroleo Brasileiro rising 4.77% to $11.85 on Friday, after five consecutive sessions in a row of gains. NYSE fell 0.11% to $15,246.36, after three consecutive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, Petroleo Brasileiro has a trailing twelve months EPS of $5.62.

PE Ratio

Petroleo Brasileiro has a trailing twelve months price to earnings ratio of 2.11. Meaning, the purchaser of the share is investing $2.11 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 50.14%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Apr 27, 2023, the estimated forward annual dividend rate is 6.39 and the estimated forward annual dividend yield is 54.08%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Petroleo Brasileiro’s stock is considered to be oversold (<=20).

More news about Petroleo Brasileiro.

6. SNDL Inc. (SNDL) – 4.72%

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through four segments: Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sells wines, beers, and spirits through wholly owned liquor stores; and private sale of recreational cannabis through wholly owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.

NASDAQ ended the session with SNDL Inc. jumping 4.72% to $1.71 on Friday while NASDAQ fell 0.35% to $12,284.74.

Earnings Per Share

As for profitability, SNDL Inc. has a trailing twelve months EPS of $-1.02.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.03%.

More news about SNDL Inc..

7. Enphase Energy (ENPH) – 4.53%

Enphase Energy, Inc., together with its subsidiaries, designs, develops, manufactures, and sells home energy solutions for the solar photovoltaic industry in the United States and internationally. The company offers semiconductor-based microinverter, which converts energy at the individual solar module level, and combines with its proprietary networking and software technologies to provide energy monitoring and control services. It also provides microinverter units and related accessories, an IQ gateway; IQ batteries; the cloud-based Enlighten monitoring service; storage solutions; and electric vehicle charging solutions; and design, proposal, permitting, and lead generation services. The company sells its solutions to solar distributors; and directly to large installers, original equipment manufacturers, strategic partners, and homeowners, as well as through its legacy product upgrade program or online store. Enphase Energy, Inc. was incorporated in 2006 and is headquartered in Fremont, California.

NASDAQ ended the session with Enphase Energy rising 4.53% to $168.08 on Friday, following the last session’s downward trend. NASDAQ dropped 0.35% to $12,284.74, after two consecutive sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Enphase Energy has a trailing twelve months EPS of $3.45.

PE Ratio

Enphase Energy has a trailing twelve months price to earnings ratio of 48.72. Meaning, the purchaser of the share is investing $48.72 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 75.69%.

More news about Enphase Energy.

8. Southwestern Energy (SWN) – 4.34%

Southwestern Energy Company, an independent energy company, engages in the exploration, development, and production of natural gas, oil, and natural gas liquids (NGLs) in the United States. It operates through two segments, Exploration and Production, and Marketing. The company focuses on the development of unconventional natural gas and oil reservoirs located in Pennsylvania, West Virginia, Ohio, and Louisiana. It also engages in the marketing and transportation of natural gas, oil, and NGLs. The company serves LNG exporters, energy companies, utilities, and industrial purchasers of natural gas. Southwestern Energy Company was incorporated in 1929 and is headquartered in Spring, Texas.

NYSE ended the session with Southwestern Energy rising 4.34% to $4.93 on Friday while NYSE fell 0.11% to $15,246.36.

Earnings Per Share

As for profitability, Southwestern Energy has a trailing twelve months EPS of $5.75.

PE Ratio

Southwestern Energy has a trailing twelve months price to earnings ratio of 0.86. Meaning, the purchaser of the share is investing $0.86 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 210.69%.

More news about Southwestern Energy.

9. Beyond Meat (BYND) – 4.31%

Beyond Meat, Inc. develops, manufactures, markets, and sells plant-based meat products in the United States and internationally. The company sells a range of plant-based meat products across the platforms of beef, pork, and poultry. It sells its products through grocery, mass merchandiser, club, convenience, and natural retailer channels, as well as various food-away-from-home channels, including restaurants, foodservice outlets, and schools. The company was formerly known as Savage River, Inc. and changed its name to Beyond Meat, Inc. in September 2018. Beyond Meat, Inc. was founded in 2009 and is headquartered in El Segundo, California.

NASDAQ ended the session with Beyond Meat rising 4.31% to $10.64 on Friday while NASDAQ fell 0.35% to $12,284.74.

: beyond meat price target cut to $12 from $20 at mizuho with analysts citing low confidence that new initiatives can move the needleMizuho Securities cut its stock price target on Beyond Meat Inc. to $12 from $20 on Friday and said material headwinds persist for the maker of plant-based substitute meat products.

Earnings Per Share

As for profitability, Beyond Meat has a trailing twelve months EPS of $-5.41.

Sales Growth

Beyond Meat’s sales growth is negative 16.2% for the current quarter and negative 17.1% for the next.

Previous days news about Beyond Meat

• Beyond meat (bynd) reports Q1 loss, tops revenue estimates. According to Zacks on Wednesday, 10 May, "While Beyond Meat has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"

More news about Beyond Meat.

10. Comcast Holdings (CCZ) – 4.28%

NYSE ended the session with Comcast Holdings rising 4.28% to $57.46 on Friday, after five sequential sessions in a row of losses. NYSE fell 0.11% to $15,246.36, after three sequential sessions in a row of losses, on what was a somewhat down trend trading session today.

PE Ratio

Comcast Holdings has a trailing twelve months price to earnings ratio of 49.03. Meaning, the purchaser of the share is investing $49.03 for every dollar of annual earnings.

Yearly Top and Bottom Value

Comcast Holdings’s stock is valued at $57.46 at 17:32 EST, way under its 52-week high of $67.00 and way higher than its 52-week low of $51.13.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Comcast Holdings’s stock is considered to be overbought (>=80).

Volatility

Comcast Holdings’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.70%, a negative 0.34%, and a positive 1.77%.

Comcast Holdings’s highest amplitude of average volatility was 8.82% (last week), 2.59% (last month), and 1.77% (last quarter).

Moving Average

Comcast Holdings’s value is above its 50-day moving average of $55.56 and under its 200-day moving average of $57.50.

More news about Comcast Holdings.

Losers Today

1. AGM Group Holdings (AGMH) – -22.45%

AGM Group Holdings Inc., an integrated technology company, focuses on ASIC chip solutions. Its ASIC chip solutions include chip design, chip research and development, and crypto miner production. It also provides fintech software services. The company offers multi-assets trading and management systems to small and mid-size broker and institutional clients; and interactive trading education website that uses subscription-based method. Its FXSC is an online trading education and social trading network platform for forex traders; and provides trading education to users through interactive trading simulation and trading contests, as well as demo trading services. In addition, the company sells technical support plans; and delivers software customization services. The company was incorporated in 2015 and is based in Wan Chai, Hong Kong.

NASDAQ ended the session with AGM Group Holdings sliding 22.45% to $1.90 on Friday while NASDAQ dropped 0.35% to $12,284.74.

Earnings Per Share

As for profitability, AGM Group Holdings has a trailing twelve months EPS of $0.96.

PE Ratio

AGM Group Holdings has a trailing twelve months price to earnings ratio of 1.98. Meaning, the purchaser of the share is investing $1.98 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 96.82%.

More news about AGM Group Holdings.

2. Wheeler Real Estate Investment Trust (WHLR) – -19.99%

Headquartered in Virginia Beach, VA, Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR ) is a fully integrated, self-managed commercial real estate investment company focused on owning and operating income-producing retail properties with a primary focus on grocery-anchored centers.

NASDAQ ended the session with Wheeler Real Estate Investment Trust dropping 19.99% to $0.84 on Friday while NASDAQ fell 0.35% to $12,284.74.

Earnings Per Share

As for profitability, Wheeler Real Estate Investment Trust has a trailing twelve months EPS of $-2.28.

Moving Average

Wheeler Real Estate Investment Trust’s value is way below its 50-day moving average of $1.31 and way under its 200-day moving average of $1.62.

Volume

Today’s last reported volume for Wheeler Real Estate Investment Trust is 70138 which is 166.73% above its average volume of 26295.

More news about Wheeler Real Estate Investment Trust.

3. VerifyMe (VRME) – -10.5%

VerifyMe, Inc., together with its subsidiary, PeriShip Global, LLC, operates as a technology solutions provider that specializes in products to connect brands with consumers and providing brands with end-to-end logistics management for their products. The company operates through two segments, VerifyMe Solutions and PeriShip Global Solutions. The VerifyMe Solutions segment offers technology solutions to connect brands with consumers allowing brand owners to gather business intelligence while engaging directly with their consumers. Its solutions provide brand protection and supply chain functions, such as counterfeit prevention, traceability, consumer engagement solutions, and authentication for labels, packaging, and products, as well as tamper-proof labels. The PeriShip Global Solutions segment offers predictive analytics for optimizing delivery of time and temperature sensitive perishable products. This segment's products include PeriTrack customer dashboard, an integrated web portal tool gives its customers an in-depth look at their shipping activities based on real-time data. It also provides call center, pre-transit, post-delivery, and weather/traffic services. The company has a strategic partnership with INX International Ink Company. The company was formerly known as LaserLock Technologies, Inc. and changed its name to VerifyMe, Inc. in July 2015. VerifyMe, Inc. was incorporated in 1999 and is headquartered in Lake Mary, Florida.

NASDAQ ended the session with VerifyMe sliding 10.5% to $1.62 on Friday while NASDAQ fell 0.35% to $12,284.74.

Earnings Per Share

As for profitability, VerifyMe has a trailing twelve months EPS of $-1.99.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -82.86%.

Previous days news about VerifyMe

• Verifyme (vrme) to post Q1 earnings: what's in store?. According to Zacks on Wednesday, 10 May, "Our proven model does not conclusively predict an earnings beat for VerifyMe this time around. "

More news about VerifyMe.

4. Zai Lab (ZLAB) – -9.26%

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. Its commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; and Qinlock to treat gastrointestinal stromal tumors. The company also develops Odronextamab to treat follicular lymphoma, diffuse large B-cell lymphoma, and other B-celllymphomas; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Margetuximab for the treatment of breast and gastroesophageal cancers; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, pancreatic cancer, and other solid tumors; and Bemarituzumab to treat gastric and gastroesophageal junction cancer. In addition, it develops Zipalertinib for the treatment of patients with EGFR exon 20 insertion NSCLC; Elzovantinib, an orally bioavailable multi-targeted kinase inhibitor; ZL-2313, an investigational oral EGFR inhibitor; ZL-1211, a humanized IgG1 monoclonal antibody that targets CLDN18.2; ZL-1218 is humanized IgG1 monoclonal antibody to induce potent antibody-dependent cellular cytotoxicity activity that enables NK cell-mediated killing of CCR8-expressing T-regs; Efgartigimod to reduce disease-causing immunoglobulin G antibodies; ZL-1102, a human nanobody targeting interleukin- 17A; Sulbactam/durlobactam for the treatment of serious infections caused by Acinetobacter; and KarXT for the treatment of psychiatric and neurological conditions. The company was incorporated in 2013 and is headquartered in Shanghai, China.

NASDAQ ended the session with Zai Lab dropping 9.26% to $33.28 on Friday, following the last session’s downward trend. NASDAQ dropped 0.35% to $12,284.74, after two successive sessions in a row of gains, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Zai Lab has a trailing twelve months EPS of $-4.32.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -36.55%.

Sales Growth

Zai Lab’s sales growth is 39.1% for the ongoing quarter and 53.2% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 41.7%, now sitting on 215.04M for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is a negative 5.6% and positive 39.6% for the next.

Moving Average

Zai Lab’s value is under its 50-day moving average of $35.04 and way under its 200-day moving average of $37.23.

More news about Zai Lab.

5. AGBA Acquisition Limited (AGBAW) – -9.09%

AGBA Group Holding Limited focuses on operating a full-service platform to banks, other financial institutions, brokers, and individual financial advisors to advise and serve its retail clients. The company offers a range of financial products, such as life insurance, pensions, property-casualty insurance, mutual funds, money lending, and real estate agency services. It also operates an health and wealth management platform that offers a range of services and value-added information in health, insurance, investments, and social sharing. The company is based in Wan Chai, Wan Chai.

NASDAQ ended the session with AGBA Acquisition Limited dropping 9.09% to $0.05 on Friday, after five consecutive sessions in a row of losses. NASDAQ slid 0.35% to $12,284.74, after two sequential sessions in a row of gains, on what was a somewhat negative trend trading session today.

More news about AGBA Acquisition Limited.

6. Bionano Genomics (BNGO) – -8.37%

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.

NASDAQ ended the session with Bionano Genomics dropping 8.37% to $0.68 on Friday, following the last session’s downward trend. NASDAQ fell 0.35% to $12,284.74, after two consecutive sessions in a row of gains, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, Bionano Genomics has a trailing twelve months EPS of $-0.49.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -45.21%.

Sales Growth

Bionano Genomics’s sales growth is 29.2% for the current quarter and 30.3% for the next.

Moving Average

Bionano Genomics’s value is way below its 50-day moving average of $1.03 and way below its 200-day moving average of $1.82.

Revenue Growth

Year-on-year quarterly revenue growth grew by 30.4%, now sitting on 27.8M for the twelve trailing months.

Volume

Today’s last reported volume for Bionano Genomics is 2341300 which is 67.68% below its average volume of 7245920.

More news about Bionano Genomics.

7. Inovio Pharmaceuticals (INO) – -8.01%

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia, including cervical, vulvar, and anal dysplasia and is under phase II/III clinical trials; INO-3107 for HPV-related recurrent respiratory rapillomatosis and is under Phase 1/2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under phase 1b trial; and INO-4500 vaccine for lassa fever, which is under phase 1b trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

NASDAQ ended the session with Inovio Pharmaceuticals falling 8.01% to $0.72 on Friday while NASDAQ slid 0.35% to $12,284.74.

Earnings Per Share

As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-1.13.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -89.97%.

Volume

Today’s last reported volume for Inovio Pharmaceuticals is 1581950 which is 69.37% below its average volume of 5165460.

More news about Inovio Pharmaceuticals.

8. Groupon (GRPN) – -7.36%

Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants; and first-party goods inventory. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.

NASDAQ ended the session with Groupon dropping 7.36% to $3.09 on Friday while NASDAQ slid 0.35% to $12,284.74.

Earnings Per Share

As for profitability, Groupon has a trailing twelve months EPS of $-8.86.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -213.9%.

Sales Growth

Groupon’s sales growth is negative 12% for the ongoing quarter and negative 9.9% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Groupon’s stock is considered to be overbought (>=80).

Revenue Growth

Year-on-year quarterly revenue growth declined by 33.6%, now sitting on 599.08M for the twelve trailing months.

Previous days news about Groupon

• : groupon posts mixed first-quarter results, keeps ‘going concern’ warning on filing. According to MarketWatch on Wednesday, 10 May, "Shares of Groupon Inc. GRPN dropped more than 1% in aftermarket Wednesday after the deals and coupons company said it was "facing serious challenges" to remain afloat and offered mixed quarterly results. "
• Groupon (grpn) reports Q1 loss, misses revenue estimates. According to Zacks on Thursday, 11 May, "While Groupon has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
• Groupon (grpn) Q1 loss beat estimates, revenues down y/y. According to Zacks on Thursday, 11 May, "At the end of the first quarter, Groupon had approximately 18.2 million active customers compared with 22.2 million at the end of the previous year’s quarter.", "For the second quarter of 2023, Groupon expects its second-quarter revenues to decline year over year at a similar rate as observed in the first quarter. "

More news about Groupon.

9. Wheeler Real Estate Investment Trust (WHLRP) – -7.19%

Headquartered in Virginia Beach, VA, Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR ) is a fully integrated, self-managed commercial real estate investment company focused on owning and operating income-producing retail properties with a primary focus on grocery-anchored centers.

NASDAQ ended the session with Wheeler Real Estate Investment Trust falling 7.19% to $1.29 on Friday, following the last session’s downward trend. NASDAQ fell 0.35% to $12,284.74, after two successive sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Wheeler Real Estate Investment Trust has a trailing twelve months EPS of $-1.868.

Yearly Top and Bottom Value

Wheeler Real Estate Investment Trust’s stock is valued at $1.29 at 17:32 EST, way below its 52-week high of $5.83 and higher than its 52-week low of $1.21.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Sep 26, 2018, the estimated forward annual dividend rate is 2.25 and the estimated forward annual dividend yield is 18.43%.

More news about Wheeler Real Estate Investment Trust.

10. Niu Technologies (NIU) – -7.06%

Niu Technologies designs, manufactures, and sells smart electric scooters in the People's Republic of China. The company offers NQi, MQi, UQi, and Gova series electric scooters and motorcycles; KQi series electric kick-scooters; NIU Aero and BQi series e-bikes; RQi and TQi series high-performance motorcycles; and YQi series hybrid motorcycles. It also provides accessories and spare parts under the NIU brand name comprising scooter accessories, such as raincoats, gloves, knee pads, storage baskets and tail boxes, smart phone holders, backrests, and locks; lifestyle accessories, which includes T-shirts, coats, sweaters and hoodies, jeans, hats, bags, jewelry, notebook, badges, key chain, and mugs; and performance upgrade components that comprises of upgraded wheels, shock absorbers, brake calipers, and carbon fiber body panels. In addition, the company, through its NIU app, offers online repair request, DIY repairs, service station locator, theft reporting, and smart services, as well as NIU cover, which provides insurance services; NIU Care that offers maintenance and reserve services in offline service stations; and NIU Wash, which provides free wash coupon on a monthly basis. Niu Technologies sells and services its products through city partners and franchised stores, distributors, and third-party e-commerce platforms and the company's online store. As of December 31, 2021, it operated through 338 city partners and 3,108 franchised stores in approximately 239 cities in the People's Republic of China; and 42 distributors in 50 countries internationally. Niu Technologies was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.

NASDAQ ended the session with Niu Technologies sliding 7.06% to $3.36 on Friday, following the last session’s downward trend. NASDAQ dropped 0.35% to $12,284.74, after two consecutive sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Niu Technologies has a trailing twelve months EPS of $-0.09.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.84%.

Volatility

Niu Technologies’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.14%, a negative 0.13%, and a positive 2.85%.

Niu Technologies’s highest amplitude of average volatility was 2.23% (last week), 1.76% (last month), and 2.85% (last quarter).

Moving Average

Niu Technologies’s worth is way under its 50-day moving average of $3.82 and way below its 200-day moving average of $4.57.

Volume

Today’s last reported volume for Niu Technologies is 123886 which is 73.04% below its average volume of 459632.

More news about Niu Technologies.

Stay up to date with our winners and losers daily report